Covestor Ltd - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 203 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
Covestor Ltd ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$20.0%4,002
-7.1%
0.00%0.0%
Q2 2023$2
-33.3%
4,306
+6.2%
0.00%
-33.3%
Q1 2023$3
-81.2%
4,053
-58.1%
0.00%
-57.1%
Q4 2022$16
-99.8%
9,680
+92.7%
0.01%
-12.5%
Q3 2022$9,0000.0%5,024
-0.1%
0.01%
+14.3%
Q2 2022$9,000
-60.9%
5,028
-23.0%
0.01%
-53.3%
Q1 2022$23,000
-45.2%
6,528
-21.8%
0.02%
-74.6%
Q4 2021$42,0008,3470.06%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 200,000$998,0000.36%
Green Alpha Advisors, LLC 72,647$363,0000.24%
Skaana Management L.P. 227,851$1,137,0000.18%
SEVEN EIGHT CAPITAL, LP 196,351$980,0000.18%
Defender Capital, LLC. 103,038$514,0000.16%
Skaana Management L.P. 206,300$1,029,0000.16%
WASATCH ADVISORS LP 4,926,125$24,581,0000.10%
Parametrica Management Ltd 16,183$81,0000.08%
Cedar Brook Financial Partners, LLC 54,500$272,0000.07%
Hennion & Walsh Asset Management, Inc. 274,703$1,371,0000.07%
View complete list of INOVIO PHARMACEUTICALS INC shareholders